Review



t 49 390 b fragilis 638r 2348 234923452 344 23472346 trna 0024 b fragilis ych46 2243 224422392 238 22422240  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 92

    Structured Review

    ATCC t 49 390 b fragilis 638r 2348 234923452 344 23472346 trna 0024 b fragilis ych46 2243 224422392 238 22422240
    T 49 390 B Fragilis 638r 2348 234923452 344 23472346 Trna 0024 B Fragilis Ych46 2243 224422392 238 22422240, supplied by ATCC, used in various techniques. Bioz Stars score: 92/100, based on 8 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/638r/Bifidobacterium+ruminantium+Biavati+and+Mattarelli/pm34379855-194-53-100
    Average 92 stars, based on 8 article reviews
    t 49 390 b fragilis 638r 2348 234923452 344 23472346 trna 0024 b fragilis ych46 2243 224422392 238 22422240 - by Bioz Stars, 2026-10
    92/100 stars

    Images

    Related Articles

    Periodic Counter-current Chromatography:

    Article Title: A Computational Framework Based on Ensemble Deep Neural Networks for Essential Genes Identification
    Article Snippet: Detail information and predictive accuracy of all species datasets Species Essential genes Our Predicted Our Accuracy Previo us work Bacillus subtilis 168 271 260 95.94 47.62 Vibrio cholerae N16961 779 439 56.35 - Streptococcus pneumoniae 244 154 63.11 53.57 Helicobacter pylori 26695 323 148 45.82 26.89 Mycobacterium tuberculosis H37Rv 614 436 71 19.7 Salmonella typhimurium LT2 230 118 51.30 27.65 Acinetobacter baylyi ADP1 499 125 25.05 58.44 Pseudomonas aeruginosa UCBPP-PA14 335 281 83.88 18.21 Staphylococcus aureus NCTC 8325 351 56 15.95 62.61 Escherichia coli MG1655 I 609 308 50.57 52.34 Escherichia coli MG1655 II 296 142 47.97 52.34 Caulobacter crescentus 480 396 82.5 61.58 Streptococcus sanguinis 218 172 78.9 52.33 Porphyromonas gingivalis ATCC 33277 463 455 98.27 55.95 Bacteroides thetaiotaomicron VPI-5482 325 197 60.62 35.08 Burkholderia thailandensis E264 406 362 89.16 47.39 Mycobacterium tuberculosis H37Rv II 771 566 73.41 19.7 Salmonella enterica subsp. enterica serovar Typhimurium str. .. 14028S 105 56 53.33 20.29 Mycobacterium tuberculosis H37Rv III 687 472 68.7 19.7 Sphingomonas wittichii RW1 535 359 67.1 43.55 Shewanella oneidensis MR-1 403 277 68.73 46.75 Pseudomonas aeruginosa PAO1 117 94 80.34 47.39 Salmonella enterica serovar Typhimurium SL1344 353 187 52.97 43.63 Salmonella enterica serovar Typhi Ty2 358 212 59.22 55.36 Bacteroides fragilis 638R 547 320 58.5 30.16 Burkholderia pseudomallei K96243 505 503 99.6 43.17 Pseudomonas aeruginosa PAO1 336 334 99.4 47.39 Streptococcus pyogenes MGAS5448 227 106 46.7 43.15 Streptococcus pyogenes NZ131 241 98 40.66 37.76 Porphyromonas gingivalis ATCC 33277 281 277 98.58 55.95 Synechococcus elongatus PCC 7942 682 606 88.86 - Rhodopseudomonas palustris CGA009 522 416 79.69 - Streptococcus agalactiae A909 317 90 28.39 - Acinetobacter baumannii ATCC 17978 458 150 32.75 - Agrobacterium fabrum str. .. C58 361 326 90.3 - Brevundimonas subvibrioides ATCC 15264 412 310 75.24 - Bacillus thuringiensis BMB171 516 150 29.07 - Escherichia coli ST131 strain EC958 315 134 42.54 - Pseudomonas aeruginosa PAO1 551 464 84.21 47.39 Burkholderia cenocepacia K56-2 508 382 75.2 - Streptococcus mutans UA159 197 61 30.96 - Neisseria gonorrhoeae MS11 751 475 63.25 - Escherichia coli O157:H7 1265 428 33.83 - Ralstonia solanacearum GMI1000 465 383 82.37 - Streptococcus suis 361 202 55.96 - Mycobacterium avium subsp. hominissuis strain MAC109 230 157 68.26 - Providencia stuartii strain BE2467 496 211 42.54 - Staphylococcus aureus subsp. aureus MSSA476 305 49 16.07 - Burkholderia cenocepacia J2315 383 235 61.36 - Vibrio cholerae C6706 343 215 62.68 39.66 Mycoplasma pneumoniae 342 302 88.3 - ‘-‘: dataset was not conducted in the previous work Supplementary Figure S1.

    other:

    Article Title: Commensal bacteria produce GPCR ligands that mimic human signaling molecules
    Article Snippet: 5 6 Clone Number EBI Gene Organism Gene Size (bp) Molecule Family 1 EFI7261 Bacteroides oral 274 F0058 1191 No production 2 EHB91285 Alistipes indistinctus YUT 12060 921 1 3 EEK17761 Porphyromonas uenonis 960 No production 5 EEY82825 Bacteroides sp 2_1_33B 987 1 6 EHP49568 Odoribacter laneus YIT 12061 969 No production 7 EHG23013 Alloprevotella rava F0323 1008 1 8 EFA42931 Prevotella bergensis DSM 17361 999 1 9 EFL47029 Prevotella disiens FB035 1005 1 10 EHO75052 Prevotella micans F0438 1005 1 11 ADK95845 Prevotella melaninogenica ATCC 25845 1011 1 12 EFV04460 Prevotella salivae DSM 15606 1017 1 13 EHH01788 Paraprevotella clara YIT 11850 945 1 14 EDY97076 Bacteroides plebius DSM 17135 1002 1 15 CBW20928 Bacteroides fragilis 638R 1026 1 16 EDS14876 Bacteroides stercoris ATCC 43183 1035 1 17 EDO52243 Bacteroides uniformis ATCC 8492 990 1 18 CBK67812 Bacteroides xylanisolvens XB1A 1029 1 19 ACI09609 Klebsiella pneumonia 342 1713 3 21 ABV66681 Acrobacter butzleri RM4018 1716 2 24 EHT12133 Klebsiella oxytoca 10-5246 1731 2 26 EFE54303 Providencia rettgeri DSM 1131 1743 2 27 EFE94777 Serratia odorifera DSM 4582 1734 2 29 EER56350 Neisseria flavescens SK114 768 No production 30 EET45812 Neisseria sicca ATCC 29256 783 4 31 ACS62992 Ralstonia pickettii 12D 846 4 33 BAH33083 Rhodococcus erythropolis PR4 849 No production 35 EFG73978 Mycobacterium parascrofulaceum ATCC BAA 614 870 No production 36 CAW29482 Pseudomonas aeruginosa LESB58 768 4 37 EFH13337 Roseomonas cervicalis ATCC 49957 813 4 38 EGP09383 Bradyrhizobiaceae bacterium SG-6C 1041 No production 39 EEV22085 Enhydrobacter aerosaccus SK60 1011 No production 40 EEY94333 Acinetobacter junii SH205 789 No production 41 EFF83269 Acinetobacter haemolyticus ATCC 19194 789 No production 42 CAP01857 Acinetobacter baumannii SDF 816 4 43 EGP10046 Bradyrhizobiaceae bacterium SG-6C 804 5 50 EFK33376 Chryseobacterium gleum ATCC 35910 1854 No production 51 EEK14630 Capnocytophaga gingivalis ATCC 33624 1815 No production 52 EFS97491 Capnocytophaga ochracea F0287 1848 2 53 CBK85930 Enterobacter cloacae NCTC 9394 1713 2 54 EHM48796 Yokenella regensburgei ATCC 43003 1713 2 55 EEK89350 Bacilus cereus m1550 1596 No production 56 EHL05550 Desulfitobacterium hafniense DP7 1638 6 57 EFV76279 Bacillus sp 2_A_57_CT2 1623 6 58 GL883582 Gemella Haemolysans M341 1576 6 1 Supplementary Info Table 2.

    Article Title: Defining the role of bacteriophage in mucosal immunity
    Article Snippet: Prophage ID Organism Mean viral read coverage length (nt) g.345.pp.1 Bifidobacterium longum DJO10A 217.2 39864 g.31087.pp.3 Bifidobacterium breve HPH0326 83.4 117203 g.1381.pp.1 Collinsella aerofaciens ATCC 25986 5.8 33756 g.31354.pp.6 Enterorhabdus caecimuris B7 0.0 60491 g.1527.pp.1 Collinsella stercoris DSM 13279 2.4 53572 g.1947.pp.2 Collinsella intestinalis DSM 13280 0.2 97506 g.1738.pp.2 Eggerthella lenta DSM 2243 5.2 40121 g.1648.pp.1 Bacteroides sp. 1 1 14 201.9 49814 g.1648.pp.4 Bacteroides sp. 1 1 14 89.0 59111 g.1599.pp.6 Bacteroides sp. 1 1 30 568.1 94623 g.1649.pp.4 Bacteroides sp. 1 1 6 17.3 74713 g.2867.pp.3 Bacteroides sp. 2 1 56FAA 123.8 55511 g.1653.pp.13 Bacteroides sp. 2 2 4 3198.8 76735 g.1616.pp.11 Bacteroides sp. 3 1 12 486.5 34734 g.1616.pp.10 Bacteroides sp. 3 1 12 9.3 51061 g.1601.pp.2 Bacteroides sp. 3 1 23 195.4 192015 g.1602.pp.4 Bacteroides sp. 3 1 33FAA 205.4 79195 g.1656.pp.9 Bacteroides sp. 3 1 40A 306.8 51263 g.3439.pp.4 Bacteroides fragilis 638R 12.0 137840 g.1606.pp.6 Bacteroides sp. 9 1 42FAA 3215.9 59172 g.1552.pp.2 Bacteroides stercoris ATCC 43183 982.0 65038 g.1368.pp.5 Bacteroides ovatus ATCC 8483 27.8 85783 g.26941.pp.2 Prevotella sp. C561 0.4 58530 g.28909.pp.6 Bacteroides dorei CL02T00C15 229.2 65252 g.28919.pp.8 Bacteroides ovatus CL02T12C04 101.0 75463 g.28919.pp.10 Bacteroides ovatus CL02T12C04 2.4 49694 g.28910.pp.10 Bacteroides dorei CL02T12C06 246.1 52339 72 Table 3-2: Taxonomic details of the 170 predicted prophage-containing regions, continued.

    Produced:

    Article Title: Characterization of Bacteroides fragilis Hemolysins and Regulation and Synergistic Interactions of HlyA and HlyB
    Article Snippet: .. When strains ATCC 25285, 638R, ATCC 23745, and VPI 2393 were grown on DM-BAP, they produced beta-hemolysis after 3 to 5 days, but much weaker activity was observed on BHIS-BAP during the same period of incubation (Fig. ). ..

    Activity Assay:

    Article Title: Characterization of Bacteroides fragilis Hemolysins and Regulation and Synergistic Interactions of HlyA and HlyB
    Article Snippet: .. When strains ATCC 25285, 638R, ATCC 23745, and VPI 2393 were grown on DM-BAP, they produced beta-hemolysis after 3 to 5 days, but much weaker activity was observed on BHIS-BAP during the same period of incubation (Fig. ). ..

    Incubation:

    Article Title: Characterization of Bacteroides fragilis Hemolysins and Regulation and Synergistic Interactions of HlyA and HlyB
    Article Snippet: .. When strains ATCC 25285, 638R, ATCC 23745, and VPI 2393 were grown on DM-BAP, they produced beta-hemolysis after 3 to 5 days, but much weaker activity was observed on BHIS-BAP during the same period of incubation (Fig. ). ..

    CRISPR:

    Article Title: Computational Methods for Studying Microbial Community Interactions
    Article Snippet: .. Odoribactersplanchnicus DSM 20712 (Type l-B) Roseburia hominis A2-183 (Type I-C) Desulfovibrio desulfuricans ATCC 27774 uid59213 (Type l—E) Dorea Iongicatena DSM 13814 (Type ll-A) Bacteroides fragilis 638R (Type "-0 Roseburia intestinalis X8684 (Type III) Eubacterium eligens ATCC 27750 (Type V) —m Figure 2.1: Subset of CRISPR—Cas systems found in common human gut—associated bacterial species used to generate reference CRISPR repeats. ..



    Similar Products

    92
    ATCC t 49 390 b fragilis 638r 2348 234923452 344 23472346 trna 0024 b fragilis ych46 2243 224422392 238 22422240
    T 49 390 B Fragilis 638r 2348 234923452 344 23472346 Trna 0024 B Fragilis Ych46 2243 224422392 238 22422240, supplied by ATCC, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/638r/Bifidobacterium+ruminantium+Biavati+and+Mattarelli/pm34379855-194-53-100
    Average 92 stars, based on 1 article reviews
    t 49 390 b fragilis 638r 2348 234923452 344 23472346 trna 0024 b fragilis ych46 2243 224422392 238 22422240 - by Bioz Stars, 2026-10
    92/100 stars
      Buy from Supplier

    90
    Rocha labs 638r hydrogen peroxide resistant
    Bacterial strains and plasmids used in this study.
    638r Hydrogen Peroxide Resistant, supplied by Rocha labs, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/638r/638r+hydrogen+peroxide+resistant/pmc11304471-37-2-11
    Average 90 stars, based on 1 article reviews
    638r hydrogen peroxide resistant - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    93
    Bio-Techne corporation histone h2ax
    Bacterial strains and plasmids used in this study.
    Histone H2ax, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/638r/Histone+H2AX+Antibody/pm37517643-46-0-28
    Average 93 stars, based on 1 article reviews
    histone h2ax - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    92
    DSMZ b fragilis 638r pip417
    Bacterial strains and plasmids used in this study.
    B Fragilis 638r Pip417, supplied by DSMZ, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/638r/Bacteroides+fragilis/pm37438331-287-0-8
    Average 92 stars, based on 1 article reviews
    b fragilis 638r pip417 - by Bioz Stars, 2026-10
    92/100 stars
      Buy from Supplier

    638r  (ATCC)
    95
    ATCC 638r
    Bacterial strains and plasmids used in this study.
    638r, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/638r/Eubacterium+eligens/lam_tony_jong_heng__2021__computational_methods_for_studying_microbial_community_interactions-211-25-35
    Average 95 stars, based on 1 article reviews
    638r - by Bioz Stars, 2026-10
    95/100 stars
      Buy from Supplier

    96
    ATCC b fragilis 638r inhibits b fragilis nctc9343
    Bacterial strains and plasmids used in this study.
    B Fragilis 638r Inhibits B Fragilis Nctc9343, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/638r/HGF-1/pm30716990-43-16-31
    Average 96 stars, based on 1 article reviews
    b fragilis 638r inhibits b fragilis nctc9343 - by Bioz Stars, 2026-10
    96/100 stars
      Buy from Supplier

    Image Search Results


    Bacterial strains and plasmids used in this study.

    Journal: MicrobiologyOpen

    Article Title: New functions of pirin proteins and a 2‐ketoglutarate: Ferredoxin oxidoreductase ortholog in Bacteroides fragilis metabolism and their impact on antimicrobial susceptibility to metronidazole and amixicile

    doi: 10.1002/mbo3.1429

    Figure Lengend Snippet: Bacterial strains and plasmids used in this study.

    Article Snippet: IB263 , 638R hydrogen peroxide resistant, hpr , Rif r , Rocha & Smith ( ) .

    Techniques: Cloning, Staining, Plasmid Preparation, Derivative Assay, Clone Assay, Expressing, Selection, Construct, Mutagenesis

    Agar dilution determination of minimal inhibitory concentration (MIC μg/mL) of metronidazole (MTZ) and amixicile (AMIX) for Bacteroides species and B. fragilis  638R  mutant strains.

    Journal: MicrobiologyOpen

    Article Title: New functions of pirin proteins and a 2‐ketoglutarate: Ferredoxin oxidoreductase ortholog in Bacteroides fragilis metabolism and their impact on antimicrobial susceptibility to metronidazole and amixicile

    doi: 10.1002/mbo3.1429

    Figure Lengend Snippet: Agar dilution determination of minimal inhibitory concentration (MIC μg/mL) of metronidazole (MTZ) and amixicile (AMIX) for Bacteroides species and B. fragilis 638R mutant strains.

    Article Snippet: IB263 , 638R hydrogen peroxide resistant, hpr , Rif r , Rocha & Smith ( ) .

    Techniques: Concentration Assay, Mutagenesis, Isolation

    Schematic representation of B. fragilis 638R chromosomal regions for PFOR, PoxB, Kor1AB, and Kor2AEBG as shown in the panels. Each locus tag is depicted below the respective deduced ORF symbolized by an arrow. The designation of the predicted peptide product is depicted above each open arrow gene region respectively. The Arrow direction depicts the transcription orientation. Arrows filled with color represent the functional annotation group assigned to PFOR (dark blue), PoxB (purple), KorA (orang), KorB (dark gray), KorG (light green), KorD (gold) or, KorC (light gray) orthologs, respectively. The deletion construct representation of each chromosomal region mutant is shown below the native chromosome region, respectively. The DNA fragment containing the promoterless kor2AEBG genes cloned into the expression vector pFD340 (pER‐377) was used for genetic complementation studies. ATPase, predicted ATPase AAA+ superfamily; DUF4870, putative membrane protein of unknown function; Kor1A, 2‐ketoglutarate ferredoxin oxidoreductase subunit α (CBW24739); Kor1B, 2‐ketoglutarate ferredoxin oxidoreductase subunit β (CBW24740); Kor2A, 2‐ketoglutarate ferredoxin oxidoreductase subunit α (CBW22186); Kor2B, 2‐ketoglutarate ferredoxin oxidoreductase subunit β (CBW22184); Kor2C, conserved hypothetical protein containing tetratricopeptide repeat (CBW22188); Kor2D, ferredoxin, 2‐ketoglutarate‐acceptor oxidoreductase subunit δ (CBW22187); Kor2E, hypothetical protein (CBW22185); Kor2G, 2‐ketoglutarate ferredoxin oxidoreductase subunit γ (CBW22183); PFOR, pyruvate:ferredoxin oxidoreductase (GenBank accession number CBW23670); PoxB, putative pyruvate dehydrogenase (CBW23720); ThPP, thiamine diphosphate cofactor.

    Journal: MicrobiologyOpen

    Article Title: New functions of pirin proteins and a 2‐ketoglutarate: Ferredoxin oxidoreductase ortholog in Bacteroides fragilis metabolism and their impact on antimicrobial susceptibility to metronidazole and amixicile

    doi: 10.1002/mbo3.1429

    Figure Lengend Snippet: Schematic representation of B. fragilis 638R chromosomal regions for PFOR, PoxB, Kor1AB, and Kor2AEBG as shown in the panels. Each locus tag is depicted below the respective deduced ORF symbolized by an arrow. The designation of the predicted peptide product is depicted above each open arrow gene region respectively. The Arrow direction depicts the transcription orientation. Arrows filled with color represent the functional annotation group assigned to PFOR (dark blue), PoxB (purple), KorA (orang), KorB (dark gray), KorG (light green), KorD (gold) or, KorC (light gray) orthologs, respectively. The deletion construct representation of each chromosomal region mutant is shown below the native chromosome region, respectively. The DNA fragment containing the promoterless kor2AEBG genes cloned into the expression vector pFD340 (pER‐377) was used for genetic complementation studies. ATPase, predicted ATPase AAA+ superfamily; DUF4870, putative membrane protein of unknown function; Kor1A, 2‐ketoglutarate ferredoxin oxidoreductase subunit α (CBW24739); Kor1B, 2‐ketoglutarate ferredoxin oxidoreductase subunit β (CBW24740); Kor2A, 2‐ketoglutarate ferredoxin oxidoreductase subunit α (CBW22186); Kor2B, 2‐ketoglutarate ferredoxin oxidoreductase subunit β (CBW22184); Kor2C, conserved hypothetical protein containing tetratricopeptide repeat (CBW22188); Kor2D, ferredoxin, 2‐ketoglutarate‐acceptor oxidoreductase subunit δ (CBW22187); Kor2E, hypothetical protein (CBW22185); Kor2G, 2‐ketoglutarate ferredoxin oxidoreductase subunit γ (CBW22183); PFOR, pyruvate:ferredoxin oxidoreductase (GenBank accession number CBW23670); PoxB, putative pyruvate dehydrogenase (CBW23720); ThPP, thiamine diphosphate cofactor.

    Article Snippet: IB263 , 638R hydrogen peroxide resistant, hpr , Rif r , Rocha & Smith ( ) .

    Techniques: Functional Assay, Construct, Mutagenesis, Clone Assay, Expressing, Plasmid Preparation, Membrane

    Disc diffusion assay sensitivity of B. fragilis strains to metronidazole (MTZ), panels A,B,C or for Amixicile (AMIX), panels D,E,F. A and D: Parent ( B. fragilis 638R). B and E: ΔfrdB (derived from ADB77, isogenic BF638R thy ‐ strain). C and F: B. fragilis BF8 strain ( nimB + ). Strain designations are depicted in each panel. For these experiments, 20 mM succinate and 50 μg/ml thymine were added to the BHIS media. Each bar represents the average zone of inhibition (mm) of at least three independent biological replicates. Vertical error bars denote the standard deviation of the means from two independent experiments in triplicate. The significance of the P value was calculated by one‐way ANOVA followed by multiple comparisons using Dunnett and Bonferroni tests. Only groups with statistical significance in both tests are reported. p < 0.05 (*), p < 0.01 (**), p < 0.001 (***), and p < 0.0001 (****). NS, not significant.

    Journal: MicrobiologyOpen

    Article Title: New functions of pirin proteins and a 2‐ketoglutarate: Ferredoxin oxidoreductase ortholog in Bacteroides fragilis metabolism and their impact on antimicrobial susceptibility to metronidazole and amixicile

    doi: 10.1002/mbo3.1429

    Figure Lengend Snippet: Disc diffusion assay sensitivity of B. fragilis strains to metronidazole (MTZ), panels A,B,C or for Amixicile (AMIX), panels D,E,F. A and D: Parent ( B. fragilis 638R). B and E: ΔfrdB (derived from ADB77, isogenic BF638R thy ‐ strain). C and F: B. fragilis BF8 strain ( nimB + ). Strain designations are depicted in each panel. For these experiments, 20 mM succinate and 50 μg/ml thymine were added to the BHIS media. Each bar represents the average zone of inhibition (mm) of at least three independent biological replicates. Vertical error bars denote the standard deviation of the means from two independent experiments in triplicate. The significance of the P value was calculated by one‐way ANOVA followed by multiple comparisons using Dunnett and Bonferroni tests. Only groups with statistical significance in both tests are reported. p < 0.05 (*), p < 0.01 (**), p < 0.001 (***), and p < 0.0001 (****). NS, not significant.

    Article Snippet: IB263 , 638R hydrogen peroxide resistant, hpr , Rif r , Rocha & Smith ( ) .

    Techniques: Diffusion-based Assay, Derivative Assay, Inhibition, Standard Deviation

    Disc diffusion assays. Susceptibility of B. fragilis 638R strain (Parent) and its isogenic ΔfrdB deletion mutant to metronidazole (MTZ). Panels (a) and (b): in the presence of 2‐hydroxy‐1,4‐napththoquinone (HNQ). Panel (c): in the presence of 1,‐4‐naphthoquinone (NQ). Panel (d): in the presence of 1,4‐benzoquinone (BQ). Panel (e): in the presence of plumbagin (PLG). Panel (f): in the presence of menadione (MD). Panel (g): in the presence of paraquat (PQ). Panel (h): in the presence of benzyl‐viologen (BV). Panels i and j: Susceptibility of B. fragilis 638 R strain to nitrofurantoin (NT), tetracycline (Tet), or chloramphenicol (Cm) exposed to oxygen with no addition (i) or addition of 50 μM HNQ (j). Each bar represents the average zone inhibition (mm) of at least three independent biological replicates. Vertical error bars denote the standard deviation of the means from two independent experiments in triplicate. Panels a–h: The significance of the p value was calculated by one‐way ANOVA followed by multiple comparisons using Dunnett and Bonferroni tests. Only groups with statistical significance in both tests are reported. p < 0.05 (*), p < 0.01 (**), p < 0.001 (***), and p < 0.0001 (****). NS, not significant. For panels i and j, no statistical analyzes were performed.

    Journal: MicrobiologyOpen

    Article Title: New functions of pirin proteins and a 2‐ketoglutarate: Ferredoxin oxidoreductase ortholog in Bacteroides fragilis metabolism and their impact on antimicrobial susceptibility to metronidazole and amixicile

    doi: 10.1002/mbo3.1429

    Figure Lengend Snippet: Disc diffusion assays. Susceptibility of B. fragilis 638R strain (Parent) and its isogenic ΔfrdB deletion mutant to metronidazole (MTZ). Panels (a) and (b): in the presence of 2‐hydroxy‐1,4‐napththoquinone (HNQ). Panel (c): in the presence of 1,‐4‐naphthoquinone (NQ). Panel (d): in the presence of 1,4‐benzoquinone (BQ). Panel (e): in the presence of plumbagin (PLG). Panel (f): in the presence of menadione (MD). Panel (g): in the presence of paraquat (PQ). Panel (h): in the presence of benzyl‐viologen (BV). Panels i and j: Susceptibility of B. fragilis 638 R strain to nitrofurantoin (NT), tetracycline (Tet), or chloramphenicol (Cm) exposed to oxygen with no addition (i) or addition of 50 μM HNQ (j). Each bar represents the average zone inhibition (mm) of at least three independent biological replicates. Vertical error bars denote the standard deviation of the means from two independent experiments in triplicate. Panels a–h: The significance of the p value was calculated by one‐way ANOVA followed by multiple comparisons using Dunnett and Bonferroni tests. Only groups with statistical significance in both tests are reported. p < 0.05 (*), p < 0.01 (**), p < 0.001 (***), and p < 0.0001 (****). NS, not significant. For panels i and j, no statistical analyzes were performed.

    Article Snippet: IB263 , 638R hydrogen peroxide resistant, hpr , Rif r , Rocha & Smith ( ) .

    Techniques: Diffusion-based Assay, Mutagenesis, Inhibition, Standard Deviation

    Metronidazole minimal Inhibitory concentration (MIC μg/mL) for B. fragilis  638R  in BHI media containing 5 μg/mL hemin ( l ‐cysteine was omitted) supplemented with 2‐hydroxy‐1,4‐naphthoquinone, or 1,4‐naphthoquinone.

    Journal: MicrobiologyOpen

    Article Title: New functions of pirin proteins and a 2‐ketoglutarate: Ferredoxin oxidoreductase ortholog in Bacteroides fragilis metabolism and their impact on antimicrobial susceptibility to metronidazole and amixicile

    doi: 10.1002/mbo3.1429

    Figure Lengend Snippet: Metronidazole minimal Inhibitory concentration (MIC μg/mL) for B. fragilis 638R in BHI media containing 5 μg/mL hemin ( l ‐cysteine was omitted) supplemented with 2‐hydroxy‐1,4‐naphthoquinone, or 1,4‐naphthoquinone.

    Article Snippet: IB263 , 638R hydrogen peroxide resistant, hpr , Rif r , Rocha & Smith ( ) .

    Techniques: Concentration Assay, Control

    Survival of B. fragilis 638R in rat tissue cage infection following AMIX treatment at 20 mg/Kg/day via intraperitoneal (a) or 0.5 mg/intra‐cage/day (b). AMIX administration started on Day 1 through Day 7 postinfection. Bacteria were grown overnight in BHIS medium and diluted in PBS to approximately 1 × 10 5 CFU/mL. Four milliliters of the suspension were inoculated into the intraperitoneal tissue cage. Fluid samples were aspirated at time points for CFU counts as described in Materials and Methods. Tissue cage fluid was aspirated at Days 1, 2, 4 and 8 postinfection. Data are expressed as the mean CFU per milliliter of intra‐abdominal tissue cage fluid from three rats. The standard errors of the means (SEM) are denoted by vertical error bars. The detection limit of 1 × 10 1 CFU/mL.

    Journal: MicrobiologyOpen

    Article Title: New functions of pirin proteins and a 2‐ketoglutarate: Ferredoxin oxidoreductase ortholog in Bacteroides fragilis metabolism and their impact on antimicrobial susceptibility to metronidazole and amixicile

    doi: 10.1002/mbo3.1429

    Figure Lengend Snippet: Survival of B. fragilis 638R in rat tissue cage infection following AMIX treatment at 20 mg/Kg/day via intraperitoneal (a) or 0.5 mg/intra‐cage/day (b). AMIX administration started on Day 1 through Day 7 postinfection. Bacteria were grown overnight in BHIS medium and diluted in PBS to approximately 1 × 10 5 CFU/mL. Four milliliters of the suspension were inoculated into the intraperitoneal tissue cage. Fluid samples were aspirated at time points for CFU counts as described in Materials and Methods. Tissue cage fluid was aspirated at Days 1, 2, 4 and 8 postinfection. Data are expressed as the mean CFU per milliliter of intra‐abdominal tissue cage fluid from three rats. The standard errors of the means (SEM) are denoted by vertical error bars. The detection limit of 1 × 10 1 CFU/mL.

    Article Snippet: IB263 , 638R hydrogen peroxide resistant, hpr , Rif r , Rocha & Smith ( ) .

    Techniques: Infection, Bacteria, Suspension

    Schematic diagram of B. fragilis 638R (a) central metabolism, (b) degradation of branched amino acids pathway, and (c) initial steps of menaquinol biosynthetic pathway. The thiamine diphosphate binding enzymes are depicted with ThPP in red font beside the enzyme designation. The enzyme subunits with predicted stable protein‐protein interaction with Pir1 are highlighted with a blue box and interaction with Pir2 with a green box. The compilation of the pathway reactions was based on public database https://www.genome.jp/pathway/bfg00020,/pathway/bfg00010,/pathway/bfg00620,/pathway/bfg00640,/pathway/bfg00280,/pathway/bfg00130 ), B. fragilis 638R genome (GenBank accession number FQ312004), and Refs.: Allison & Robinson, ; Allison et al., ; Butler et al., ; Harris & Reddy, ; Ito et al., ; Macy et al., ; Rios‐Covian et al., ; Schofield et al., ; Sund et al., ;. Zhang et al., . Orange dash/dot arrows indicate there is no report that 2‐ketoglutrate or l ‐glutamate is formed from isocitrate dehydrogenase (Icd) pathway under anaerobic conditions (Allison & Robinson, ; Allison et al., ; Schofield et al., ). AAs, amino acids; AckA, acetate kinase (BF638R_0490); AcnA, aconitase (BF638R_3569); AcoA/AcoB, 2‐Ketoisovalerate dehydrogenase, a single peptide containing alpha‐ and beta‐subunit domains (BF638R_1637); Acs, acetate,CoA ligase (BF638R_4449); AEP‐AT, 2‐aminoethylphosphonate aminotransferase (BF638R_1869) and (BF638R_3511); BCAAT, branched‐chain amino acid transferase (BF638R_3846); CitS_II/ACL, citrate synthase/2‐methylcitrate synthase/ACL family (BF638R_3567); Fp, flavoprotein; Frd, fumarate reductase, FrdCAB (BF638R_4499‐4501); FumB, fumarate hydratase class I, anaerobic (BF638R_0646); Icd, isocitrate dehydrogenase (BF638R_3568); IM, inner cytoplasmic membrane; Kor1AB, 2‐Ketoglutarate ferredoxin oxidoreductase (BF638R_4321‐4322); Kor2CDAEBG, 2‐Ketoglutarate ferredoxin oxidoreductase (BF638R_1660‐1665); LdhA, d ‐Lactate dehydrogenase (BF638R_1473); Lpd1, dihydrolipoamide dehydrogenase‐E3 (BF638R_0023); Lpd2, dihydrolipoamide dehydrogenase‐E3 (BF638R_1634); MaeB, malate dehydrogenase [oxaloacetate‐decarboxylating NADP + ‐dependent] (BF638R_3435); Mdh, malate dehydrogenase (BF638R_0537); MenD, 2‐Succinyl‐5‐enolpyruvyl‐6‐hydroxy‐3‐cyclohexene‐1‐carboxylic‐acid synthase (BF638R_1316); MenF, isochorismate synthase (BF638R_1315); MK, menaquinone; MMCE, methylmalonyl‐CoA epimerase (BF638R_3151); MmdA1 (PccB), propionyl‐CoA carboxylase beta‐chain (BF638R_1625); MmdA2 (PccB), propionyl‐CoA carboxylase beta‐chain (BF638R_3367); MutAB, methylmalonyl‐CoA mutase, small (A) and large (B) subunits (BF638R_3616‐3615); Nad2, NADH dehydrogenase, FAD‐containing subunit (BF638R_1612); Nqr, Na+‐translocating NADH‐quinone oxidoreductase, NqrABCDE, (BF638R_2136_2140); Nuo, NADH,ubiquinone oxidoreductase, NuoABC/DHIJKLMN (BF638R_0850‐0841); OadA1, pyruvate/oxaloacetate carboxyltransferase (BF638R_2828); OM, outer membrane; PckA, phosphoenolpyruvate carboxykinase (BF638R_4326); PEP mutase, phosphoenolpyruvate mutase (BF638R_1867); PFLA, phospholipid fatty acids; PflA, pyruvate formate‐lyase 1, activating enzyme (BF638R_1338); PflB, pyruvate formate‐lyase 1 [formate acetyltransferase 1] (BF638R_1339); PflC, pyruvate formate‐lyase 2, activating enzyme (BF638R_4262); PflD, pyruvate formate‐lyase 2 [formate acetyltransferase 2] 9BF638R_4263); PFOR, pyruvate ferredoxin oxidoreductase (BF638R_3194); Pnpyr‐DC, phosphonopyruvate decarboxylase (BF638R_1868); PoxB, an inner membrane enzyme that catalyzes oxidative decarboxylation of pyruvate to form acetate + CO 2 (BF638R_3245); PpdK, pyruvate orthophosphate dikinase (BF638R_2565); PtaA, phosphate acetyltransferase (BF638R_0489); PycB, pyruvate carboxylase biotin‐containing subunit (BF638R_1927); Pyk, pyruvate kinase (BF638R_4359); SucDC, succinyl‐CoA synthase alpha‐ and beta‐chains (BF638R_2360‐2361); YgfH, succinate‐CoA transferase subfamily (BF638R_0025).

    Journal: MicrobiologyOpen

    Article Title: New functions of pirin proteins and a 2‐ketoglutarate: Ferredoxin oxidoreductase ortholog in Bacteroides fragilis metabolism and their impact on antimicrobial susceptibility to metronidazole and amixicile

    doi: 10.1002/mbo3.1429

    Figure Lengend Snippet: Schematic diagram of B. fragilis 638R (a) central metabolism, (b) degradation of branched amino acids pathway, and (c) initial steps of menaquinol biosynthetic pathway. The thiamine diphosphate binding enzymes are depicted with ThPP in red font beside the enzyme designation. The enzyme subunits with predicted stable protein‐protein interaction with Pir1 are highlighted with a blue box and interaction with Pir2 with a green box. The compilation of the pathway reactions was based on public database https://www.genome.jp/pathway/bfg00020,/pathway/bfg00010,/pathway/bfg00620,/pathway/bfg00640,/pathway/bfg00280,/pathway/bfg00130 ), B. fragilis 638R genome (GenBank accession number FQ312004), and Refs.: Allison & Robinson, ; Allison et al., ; Butler et al., ; Harris & Reddy, ; Ito et al., ; Macy et al., ; Rios‐Covian et al., ; Schofield et al., ; Sund et al., ;. Zhang et al., . Orange dash/dot arrows indicate there is no report that 2‐ketoglutrate or l ‐glutamate is formed from isocitrate dehydrogenase (Icd) pathway under anaerobic conditions (Allison & Robinson, ; Allison et al., ; Schofield et al., ). AAs, amino acids; AckA, acetate kinase (BF638R_0490); AcnA, aconitase (BF638R_3569); AcoA/AcoB, 2‐Ketoisovalerate dehydrogenase, a single peptide containing alpha‐ and beta‐subunit domains (BF638R_1637); Acs, acetate,CoA ligase (BF638R_4449); AEP‐AT, 2‐aminoethylphosphonate aminotransferase (BF638R_1869) and (BF638R_3511); BCAAT, branched‐chain amino acid transferase (BF638R_3846); CitS_II/ACL, citrate synthase/2‐methylcitrate synthase/ACL family (BF638R_3567); Fp, flavoprotein; Frd, fumarate reductase, FrdCAB (BF638R_4499‐4501); FumB, fumarate hydratase class I, anaerobic (BF638R_0646); Icd, isocitrate dehydrogenase (BF638R_3568); IM, inner cytoplasmic membrane; Kor1AB, 2‐Ketoglutarate ferredoxin oxidoreductase (BF638R_4321‐4322); Kor2CDAEBG, 2‐Ketoglutarate ferredoxin oxidoreductase (BF638R_1660‐1665); LdhA, d ‐Lactate dehydrogenase (BF638R_1473); Lpd1, dihydrolipoamide dehydrogenase‐E3 (BF638R_0023); Lpd2, dihydrolipoamide dehydrogenase‐E3 (BF638R_1634); MaeB, malate dehydrogenase [oxaloacetate‐decarboxylating NADP + ‐dependent] (BF638R_3435); Mdh, malate dehydrogenase (BF638R_0537); MenD, 2‐Succinyl‐5‐enolpyruvyl‐6‐hydroxy‐3‐cyclohexene‐1‐carboxylic‐acid synthase (BF638R_1316); MenF, isochorismate synthase (BF638R_1315); MK, menaquinone; MMCE, methylmalonyl‐CoA epimerase (BF638R_3151); MmdA1 (PccB), propionyl‐CoA carboxylase beta‐chain (BF638R_1625); MmdA2 (PccB), propionyl‐CoA carboxylase beta‐chain (BF638R_3367); MutAB, methylmalonyl‐CoA mutase, small (A) and large (B) subunits (BF638R_3616‐3615); Nad2, NADH dehydrogenase, FAD‐containing subunit (BF638R_1612); Nqr, Na+‐translocating NADH‐quinone oxidoreductase, NqrABCDE, (BF638R_2136_2140); Nuo, NADH,ubiquinone oxidoreductase, NuoABC/DHIJKLMN (BF638R_0850‐0841); OadA1, pyruvate/oxaloacetate carboxyltransferase (BF638R_2828); OM, outer membrane; PckA, phosphoenolpyruvate carboxykinase (BF638R_4326); PEP mutase, phosphoenolpyruvate mutase (BF638R_1867); PFLA, phospholipid fatty acids; PflA, pyruvate formate‐lyase 1, activating enzyme (BF638R_1338); PflB, pyruvate formate‐lyase 1 [formate acetyltransferase 1] (BF638R_1339); PflC, pyruvate formate‐lyase 2, activating enzyme (BF638R_4262); PflD, pyruvate formate‐lyase 2 [formate acetyltransferase 2] 9BF638R_4263); PFOR, pyruvate ferredoxin oxidoreductase (BF638R_3194); Pnpyr‐DC, phosphonopyruvate decarboxylase (BF638R_1868); PoxB, an inner membrane enzyme that catalyzes oxidative decarboxylation of pyruvate to form acetate + CO 2 (BF638R_3245); PpdK, pyruvate orthophosphate dikinase (BF638R_2565); PtaA, phosphate acetyltransferase (BF638R_0489); PycB, pyruvate carboxylase biotin‐containing subunit (BF638R_1927); Pyk, pyruvate kinase (BF638R_4359); SucDC, succinyl‐CoA synthase alpha‐ and beta‐chains (BF638R_2360‐2361); YgfH, succinate‐CoA transferase subfamily (BF638R_0025).

    Article Snippet: IB263 , 638R hydrogen peroxide resistant, hpr , Rif r , Rocha & Smith ( ) .

    Techniques: Binding Assay, Membrane